Marshall Sommer
Analyst
Rare Disease Expert
Equibles does not estimate personal net worth.
About Marshall Sommer
Marshall Sommer is recorded as Analyst at Rare Disease Expert. Marshall Sommer has spoken on 1 investor event across 1 company, most recently for Arcturus Therapeutics Holdings Inc. on August 11, 2026. The companies whose calls Marshall Sommer spoke on are classified in the Healthcare sector.
Marshall Sommer on recent calls
“You've just seen the Phase II data, so let me tell you what a metabolic physician takes from it. The result that persuades me is glutamine. Every participant entered the study with an elevated glutamine despite a normal ammonia, which is precisely the profile of the patient we call well-controlled.”
Affiliation history
-
Rare Disease Expert
Analyst
Transcript header (unverified)
Current